Submitted by amarin on Fri, 10/04/2019 - 19:25 Home ID Reference 17966 News title Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients
